The Patent Finder

Osaka Bioscience Institute

Also on record
Records under this name other than patents Osaka Bioscience Institute holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Osaka Bioscience Institute

PatentTitleStatus Expires Confidence
US 9,198,427Animal repellent
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,658,390Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases
Formerly held
Lapsed on the fee record
Ended Feb 25, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 25, 2026From the USPTO record
US 6,348,334DNA encoding Fas ligand
Formerly held
Term ended
Term ended Feb 19, 2019 · From the USPTO record
Term endedTerm ended Feb 19, 2019From the USPTO record
US 7,128,905Method of treating graft versus host disease by administration of a Fas antagonist
Lapsed on the fee record
Ended Oct 31, 2018 · From the USPTO record
Lapsed on the fee recordEnded Oct 31, 2018From the USPTO record
US 6,270,998DNA coding for human cell surface antigen
Formerly held
Term ended
Term ended Aug 7, 2018 · From the USPTO record
Term endedTerm ended Aug 7, 2018From the USPTO record
US 7,760,925Method for automatically detecting degenerated regions in stained thin section slides
Lapsed on the fee record
Ended Jul 20, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jul 20, 2018From the USPTO record
US 6,605,705Prostaglandin D synthase-specific monoclonal antibody
Formerly held
Term ended
Term ended Apr 28, 2018 · From the USPTO record
Term endedTerm ended Apr 28, 2018From the USPTO record
US 7,622,554FAS ligand derived polypeptides
Formerly held
Term ended
Term ended Sep 8, 2015 · From the USPTO record
Term endedTerm ended Sep 8, 2015From the USPTO record
US 7,238,718Method for Treating Myolytic Disease and Method for Screening Antimyolytic Agent
Lapsed on the fee record
Ended Jul 3, 2015 · High confidence
Lapsed on the fee recordEnded Jul 3, 2015High confidence
US 7,858,346Regeneration and Neogenesis of Retinal Visual Cell-Expressing OTX2 Protein
Formerly held
Lapsed on the fee record
Ended Dec 28, 2014 · High confidence
Lapsed on the fee recordEnded Dec 28, 2014High confidence
10 of 28 patents shown.
Pro members see all 28.
Pro members: see all 28 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited